Clinical trial
Zusanli (ST36) Acupoint Injection With Anisodamine for Postoperative Nausea and Vomiting in Women Following Bariatric Surgery: A Single-center Study
NCT05240482 is registered in ClinicalTrials.gov with The Second Hospital of Anhui Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Zusanli (ST36) Acupoint Injection With Anisodamine for Postoperative Nausea and Vomiting in Women Following Bariatric Surgery: A Single-center Study
- Lead sponsor
- The Second Hospital of Anhui Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 20, 2022
- Completion date
- July 6, 2022
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.